TTR fibril inhibition assay

JH Jeffrey N. Higaki
AC Avi Chakrabartty
NG Natalie J. Galant
KH Kevin C. Hadley
BH Bradley Hammerson
TN Tarlochan Nijjar
RT Ronald Torres
JT Jose R. Tapia
JS Joshua Salmans
RB Robin Barbour
ST Stephen J. Tam
KF Ken Flanagan
WZ Wagner Zago
GK Gene G. Kinney
ask Ask a question
Favorite

A stock solution of TTR-V122I (approximately 5 mg/mL) was diluted into buffer with final concentrations of 0.2 mg/mL TTR, 30 mM sodium acetate, 5 mM sodium phosphate, 100 mM KCl, 1 mM EDTA, 0.02% sodium azide, and varying concentrations of mAb at pH 7.2. This sample was dialyzed against the same buffer at pH 4.5 for 3 h at room temperature. Samples were then incubated at 37 °C for 72 h. The extent of fibril formation was probed by Thioflavin T (ThT) (Sigma-Aldrich, St Louis, MO). A five-fold molar excess of ThT was added to each sample and left at room temperature for 30 min before measurements were taken. ThT fluorescence was monitored using a Photon Technology International C60 spectrofluorometer. The photomultiplier gain was varied and excitation and emission slit widths set to 2–4 nm to maximize signal to noise. Fluorescence measurements were made using 430 and 480 nm as excitation and emission wavelengths, respectively.

The ThT fluorescence was normalized with the following formula to enable comparison of fluorescence measurements taken on different days:

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A